We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

CEM Corporation Sells 100th Automated Peptide Synthesizer

News   Mar 07, 2007

 
CEM Corporation Sells 100th Automated Peptide Synthesizer
 
 
 

RELATED ARTICLES

Novel ALS Therapy in Human Clinical Trials

News

A phase one/two clinical trial has launched to investigate whether a drug could benefit people with ALS whose disease is caused by mutations in a gene called SOD1

READ MORE

Lab Innovations 2018 – Registration Opens and Keynotes Announced

News

Learn and earn CPD points at the UK’s only lab-dedicated showcase and scientific seminar series.

READ MORE

BioAscent Secures Investment to Expand its Integrated Drug Discovery Services

News

£1.6m investment recognises BioAscent’s unique capabilities.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE